share_log

与顶尖科学家合作开发的ATS 2024由瑞思迈支持的新研究为气道正压疗法的有效性和关键作用提供了证据

A new ResMed-supported ATS 2024 study developed in collaboration with top scientists provides evidence of the efficacy and critical role of positive airway pressure therapy

Zhitong Finance ·  May 23 21:06
A new ResMed-supported ATS 2024 study developed in collaboration with top scientists provides evidence of the efficacy and critical role of positive airway pressure therapy

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment